Apollo Medical Valuation

3AM Stock  EUR 20.60  0.80  3.74%   
At this time, the firm appears to be overvalued. Apollo Medical Holdings shows a prevailing Real Value of €17.3 per share. The current price of the firm is €20.6. Our model approximates the value of Apollo Medical Holdings from analyzing the firm fundamentals such as EBITDA of 112.08 M, current valuation of 1.28 B, and Price To Sales of 1.29 X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
20.60
Please note that Apollo Medical's price fluctuation is not too volatile at this time. Calculation of the real value of Apollo Medical Holdings is based on 3 months time horizon. Increasing Apollo Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Apollo stock is determined by what a typical buyer is willing to pay for full or partial control of Apollo Medical Holdings. Since Apollo Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Apollo Stock. However, Apollo Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  20.6 Real  17.3 Hype  20.6 Naive  22.29
The real value of Apollo Stock, also known as its intrinsic value, is the underlying worth of Apollo Medical Holdings Company, which is reflected in its stock price. It is based on Apollo Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Apollo Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
17.30
Real Value
22.66
Upside
Estimating the potential upside or downside of Apollo Medical Holdings helps investors to forecast how Apollo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Apollo Medical more accurately as focusing exclusively on Apollo Medical's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
19.9620.9121.86
Details
Hype
Prediction
LowEstimatedHigh
17.5720.6023.63
Details
Naive
Forecast
LowNext ValueHigh
19.2622.2925.33
Details

Apollo Medical Total Value Analysis

Apollo Medical Holdings is presently estimated to have takeover price of 1.28 B with market capitalization of 197.6 M, debt of 203.39 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Apollo Medical fundamentals before making investing decisions based on enterprise value of the company

Apollo Medical Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Apollo implies not a very effective usage of assets in July.

Apollo Medical Profitability Analysis

The company reported the revenue of 1.14 B. Net Income was 49.05 M with profit before overhead, payroll, taxes, and interest of 0.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Apollo Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Apollo Medical and how it compares across the competition.

About Apollo Medical Valuation

The stock valuation mechanism determines Apollo Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Apollo Medical. We calculate exposure to Apollo Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Apollo Medical's related companies.

8 Steps to conduct Apollo Medical's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Apollo Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Apollo Medical's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Apollo Medical's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Apollo Medical's revenue streams: Identify Apollo Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Apollo Medical's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Apollo Medical's growth potential: Evaluate Apollo Medical's management, business model, and growth potential.
  • Determine Apollo Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Apollo Medical's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Apollo Stock analysis

When running Apollo Medical's price analysis, check to measure Apollo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apollo Medical is operating at the current time. Most of Apollo Medical's value examination focuses on studying past and present price action to predict the probability of Apollo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apollo Medical's price. Additionally, you may evaluate how the addition of Apollo Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Fundamental Analysis
View fundamental data based on most recent published financial statements
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world